# Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan

> **NCT03615846** · — · UNKNOWN · sponsor: **Accriva Diagnostics** · enrollment: 147 (actual)

## Conditions studied

- Platelet Aggregation
- Coronary Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03615846
- **Lead sponsor:** Accriva Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-15
- **Primary completion:** 2021-10-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03615846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03615846, "Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03615846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*